7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Vaccinex, Inc
(NASDAQ:VCNX) 

VCNX stock logo

Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune diso...

Founded: 2001
Full Time Employees: 45
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
Vaccinex Days Payable Outstanding ttm (DPO)
202110 202111 202112 202201 202202 202203 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 024.9549.974.8599.8124.75149.7174.65Thousand
Vaccinex Days Receivable Outstanding ttm (DSO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -511-350.09-189.18-28.27132.64293.56454.47615.38
Vaccinex Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -19.31-16.55-13.79-11.03-8.27-5.52-2.760
Vaccinex Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -19.38-16.61-13.84-11.08-8.31-5.54-2.770
Vaccinex Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.250.490.740.981.231.471.72
Vaccinex P/S ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -118.55-95.6-72.64-49.69-26.74-3.7819.1742.12
Vaccinex (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -3.06-2.62-2.18-1.75-1.31-0.87-0.440
Vaccinex P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -157.12-133.43-109.74-86.05-62.36-38.67-14.978.72
No extra charts and metrics for this ticker.